stockportfolio.pro
Stocks / MRNA vs STE
MRNA vs STE
Moderna, Inc. and STERIS plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Moderna, Inc. (MRNA) | STERIS plc (STE) | |
|---|---|---|
| Market cap | $20.7B | $20.1B |
| Revenue (latest FY) | $1.94B | $5.94B |
| Net income (latest FY) | $-2.82B | $782.30M |
| Revenue growth (5y CAGR) | 19.3% | 13.8% |
| Net margin | -145.2% | 13.2% |
| Return on equity | -32.6% | 10.9% |
| P/E ratio | — | 26.0 |
| Dividend yield | — | 1.2% |
| Profitable years (of last 10) | 2 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open MRNA — free Open STE — freeFrequently asked questions
Which is bigger, MRNA or STE?
Moderna, Inc. is larger by market capitalization — $20.7B versus $20.1B.
Which grows faster, MRNA or STE?
Over the last five fiscal years, Moderna, Inc. grew revenue faster — 19.3%/yr versus 13.8%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.